pd 169316 has been researched along with Eye Cancer, Retinoblastoma in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poulaki, V | 1 |
| Mitsiades, CS | 1 |
| Joussen, AM | 1 |
| Lappas, A | 1 |
| Kirchhof, B | 1 |
| Mitsiades, N | 1 |
1 other study available for pd 169316 and Eye Cancer, Retinoblastoma
| Article | Year |
|---|---|
Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.
Topics: Antineoplastic Agents; Apoptosis; Calpain; Caspase 3; Caspases; Cell Survival; Dipeptides; DNA; Doxo | 2002 |